160 related articles for article (PubMed ID: 10673178)
21. Predictors of bronchial hyperresponsiveness in chronic rhinosinusitis with nasal polyp.
Han DH; Kim SW; Cho SH; Kim DY; Lee CH; Kim SS; Rhee CS
Allergy; 2009 Jan; 64(1):118-22. PubMed ID: 19120071
[TBL] [Abstract][Full Text] [Related]
22. Bronchial responsiveness, spirometry and mortality in a cohort of adults.
Becker EC; Wölke G; Heinrich J
J Asthma; 2013 May; 50(4):427-32. PubMed ID: 23343387
[TBL] [Abstract][Full Text] [Related]
23. Bronchial responsiveness to adenosine 5'-monophosphate (AMP) and methacholine differ in their relationship with airway allergy and baseline FEV(1).
De Meer G; Heederik D; Postma DS
Am J Respir Crit Care Med; 2002 Feb; 165(3):327-31. PubMed ID: 11818315
[TBL] [Abstract][Full Text] [Related]
24. Is nasal polyposis a determinant of bronchial hyperresponsiveness and altered quality of life in asthmatic subjects? A case-control study.
Riccioni G; Bucciarelli T; Di Ilio C; Corradi F; Vecchia RD; Staniscia T; Mattei PA; D'Orazio N
Ann Clin Lab Sci; 2006; 36(2):170-3. PubMed ID: 16682513
[TBL] [Abstract][Full Text] [Related]
25. Treatment outcomes and predictors for systemic steroids in nasal polyposis.
Won TB; Jang E; Min SK; Kim SW
Acta Otolaryngol; 2012 Jun; 132 Suppl 1():S82-7. PubMed ID: 22582788
[TBL] [Abstract][Full Text] [Related]
26. Intranasal corticosteroid administration reduces nonspecific bronchial hyperresponsiveness and improves asthma symptoms.
Agondi RC; Machado ML; Kalil J; Giavina-Bianchi P
J Asthma; 2008 Nov; 45(9):754-7. PubMed ID: 18972290
[TBL] [Abstract][Full Text] [Related]
27. A 10-year open follow-up of eczema and respiratory symptoms in patients with atopic dermatitis treated with topical tacrolimus for the first 4 years.
Mandelin JM; Remitz A; Virtanen HM; Malmberg LP; Haahtela T; Reitamo S
J Dermatolog Treat; 2010 May; 21(3):167-70. PubMed ID: 20394492
[TBL] [Abstract][Full Text] [Related]
28. Olfaction in patients with nasal polyposis: effects of systemic steroids and radical ethmoidectomy with middle turbinate resection (nasalization).
Jankowski R; Bodino C
Rhinology; 2003 Dec; 41(4):220-30. PubMed ID: 14750349
[TBL] [Abstract][Full Text] [Related]
29. Bronchial hyperresponsiveness in pediatric rhinitis patients: the difference between allergic and nonallergic rhinitis.
Kim SW; Han DH; Lee SJ; Lee CH; Rhee CS
Am J Rhinol Allergy; 2013; 27(3):e63-8. PubMed ID: 23710946
[TBL] [Abstract][Full Text] [Related]
30. Allergic rhinitis and onset of bronchial hyperresponsiveness: a population-based study.
Shaaban R; Zureik M; Soussan D; Antó JM; Heinrich J; Janson C; Künzli N; Sunyer J; Wjst M; Burney PG; Neukirch F; Leynaert B
Am J Respir Crit Care Med; 2007 Oct; 176(7):659-66. PubMed ID: 17615387
[TBL] [Abstract][Full Text] [Related]
31. Benefits of induced sputum for the evaluation of therapeutic efficacy in patients with bronchial asthma.
Ohnishi H; Maeda H; Nishimura Y; Yokoyama M
Kobe J Med Sci; 1998 Aug; 44(4):149-61. PubMed ID: 10352494
[TBL] [Abstract][Full Text] [Related]
32. Bronchial hyperresponsiveness in children and adolescents with Crohn's disease.
Mansi A; Cucchiara S; Greco L; Sarnelli P; Pisanti C; Franco MT; Santamaria F
Am J Respir Crit Care Med; 2000 Mar; 161(3 Pt 1):1051-4. PubMed ID: 10712362
[TBL] [Abstract][Full Text] [Related]
33. Risk factors for growth and decline of lung function in asthmatic individuals up to age 42 years. A 30-year follow-up study.
Grol MH; Gerritsen J; Vonk JM; Schouten JP; Koëter GH; Rijcken B; Postma DS
Am J Respir Crit Care Med; 1999 Dec; 160(6):1830-7. PubMed ID: 10588593
[TBL] [Abstract][Full Text] [Related]
34. Evolution of symptoms associated to nasal polyposis following oral steroid treatment and nasalization of the ethmoid--radical ethmoidectomy is functional surgery for NPS.
Jankowski R; Bodino C
Rhinology; 2003 Dec; 41(4):211-9. PubMed ID: 14750348
[TBL] [Abstract][Full Text] [Related]
35. Adult patients may outgrow their asthma: a 25-year follow-up study.
Panhuysen CI; Vonk JM; Koëter GH; Schouten JP; van Altena R; Bleecker ER; Postma DS
Am J Respir Crit Care Med; 1997 Apr; 155(4):1267-72. PubMed ID: 9105065
[TBL] [Abstract][Full Text] [Related]
36. PEF variability, bronchial responsiveness and their relation to allergy markers in a random population (20-70 yr).
Boezen HM; Postma DS; Schouten JP; Kerstjens HA; Rijcken B
Am J Respir Crit Care Med; 1996 Jul; 154(1):30-5. PubMed ID: 8680695
[TBL] [Abstract][Full Text] [Related]
37. Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group.
Sont JK; Willems LN; Bel EH; van Krieken JH; Vandenbroucke JP; Sterk PJ
Am J Respir Crit Care Med; 1999 Apr; 159(4 Pt 1):1043-51. PubMed ID: 10194144
[TBL] [Abstract][Full Text] [Related]
38. [Sino-nasal polyposis. Evaluation of the efficacy of combined local and general corticotherapy in a series of 100 consecutive patients with a 3-year follow-up].
Norès JM; Avant P; Bonfils P
Bull Acad Natl Med; 2002; 186(9):1643-56; discussion 1656-8. PubMed ID: 14556579
[TBL] [Abstract][Full Text] [Related]
39. Bronchial hyperreactivity and spirometric impairment in patients with perennial allergic rhinitis.
Ciprandi G; Cirillo I; Tosca MA; Vizzaccaro A
Int Arch Allergy Immunol; 2004 Jan; 133(1):14-8. PubMed ID: 14646374
[TBL] [Abstract][Full Text] [Related]
40. Relation of the course of bronchial responsiveness from age 9 to age 15 to allergy.
Burrows B; Sears MR; Flannery EM; Herbison GP; Holdaway MD; Silva PA
Am J Respir Crit Care Med; 1995 Oct; 152(4 Pt 1):1302-8. PubMed ID: 7551386
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]